Ibrahim et al. reported that GSDME methylation exhibited potential as a prognostic biomarker of colorectal cancer and pan-cancer (Ibrahim et al., 2019a) (Ibrahim et al., 2019b). This evidence concerns the gene GSDME and colorectal cancer.